Shinichi Uchida Selected Research

Nephrogenic Diabetes Insipidus

1/2022	Congenital nephrogenic diabetes insipidus presenting as osmotic demyelination syndrome in infancy: A case report.
12/2018	AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.
6/2018	Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus.
11/2016	Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.
6/2013	Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.
5/2007	A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.
9/2006	Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.
12/2003	A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
1/2003	Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.
2/2002	Water intake and 24-hour blood pressure monitoring in a patient with nephrogenic diabetes insipidus caused by a novel mutation of the vasopressin V2R gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinichi Uchida Research Topics

Disease

34	Pseudohypoaldosteronism 11/2020 - 12/2005
32	Hypertension (High Blood Pressure) 01/2021 - 12/2005
12	Hyperkalemia 01/2020 - 07/2005
11	Chronic Renal Insufficiency 05/2021 - 03/2012
10	Nephrogenic Diabetes Insipidus 01/2022 - 02/2002
9	Renal Insufficiency (Renal Failure) 06/2022 - 01/2016
7	Gitelman Syndrome 01/2022 - 11/2010
6	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 06/2013
6	Hypokalemia 01/2022 - 10/2009
6	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 03/2003
5	Bartter Syndrome (Syndrome, Bartter) 10/2021 - 08/2002
4	Fibrosis (Cirrhosis) 05/2021 - 10/2017
4	Proteinuria 01/2021 - 10/2011
4	Infections 06/2020 - 01/2017
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 10/2012
4	Alkalosis 01/2019 - 10/2009
4	Acidosis 06/2016 - 10/2006
3	Brain Diseases (Brain Disorder) 01/2022 - 01/2015
3	Polyuria 04/2021 - 06/2018
3	Cognitive Dysfunction 07/2019 - 09/2010
3	Albuminuria 01/2019 - 10/2017
3	Anemia 12/2018 - 02/2011
3	Hypertrophy 01/2018 - 04/2005
3	Glomerulonephritis 01/2017 - 10/2011
3	Ischemia 11/2012 - 12/2005
3	Hypotension (Low Blood Pressure) 12/2010 - 10/2009
2	Hypernatremia 01/2022 - 04/2021
2	Hyperaldosteronism (Conn Syndrome) 01/2022 - 05/2020
2	Inflammation (Inflammations) 05/2021 - 01/2018
2	Hypercalcemia (Milk Alkali Syndrome) 04/2021 - 01/2010
2	Hyperparathyroidism 04/2021 - 03/2012
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021 - 06/2013
2	Nephritis 06/2020 - 01/2017
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2020 - 01/2019
2	Amnesia (Dissociative Amnesia) 07/2019 - 12/2018
2	Bacteremia 06/2019 - 11/2018
2	Heart Diseases (Heart Disease) 01/2019 - 02/2011
2	Atherosclerosis 12/2018 - 12/2017
2	Heart Failure 12/2018 - 01/2017
2	Hemorrhage 05/2018 - 01/2018
2	Cysts 01/2018 - 01/2014
2	Diabetes Mellitus 01/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

29	Phosphotransferases (Kinase)IBA 01/2020 - 10/2006
20	SaltsIBA 10/2021 - 11/2010
20	Lysine (L-Lysine)FDA Link 01/2020 - 12/2008
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
12	SodiumIBA 01/2022 - 10/2012
9	Alanine (L-Alanine)FDA Link 01/2020 - 11/2010
9	Proline (L-Proline)FDA Link 01/2020 - 11/2010
6	DiureticsIBA 01/2022 - 09/2015
6	Cullin Proteins (Cullins)IBA 11/2020 - 07/2013
6	Member 3 Solute Carrier Family 12IBA 01/2019 - 01/2013
6	Vasopressins (Vasopressin)IBA 01/2019 - 02/2002
5	Pharmaceutical PreparationsIBA 01/2021 - 10/2011
5	PotassiumIBA 01/2020 - 07/2005
5	ChloridesIBA 01/2019 - 12/2015
5	CreatinineIBA 01/2019 - 04/2010
4	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2022 - 02/2002
4	CalciumIBA 04/2021 - 01/2010
4	AlbuminsIBA 01/2021 - 08/2016
4	Sodium Chloride SymportersIBA 01/2020 - 12/2005
4	Aquaporins (Water Channels)IBA 06/2018 - 12/2003
4	ThiazidesIBA 01/2016 - 01/2003
3	Parathyroid Hormone (Parathormone)IBA 04/2021 - 08/2016
3	AldosteroneIBA 01/2020 - 09/2014
3	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 07/2013
3	Immunoglobulin G (IgG)IBA 06/2019 - 01/2017
3	AntibodiesIBA 06/2019 - 11/2013
3	Hemoglobins (Hemoglobin)IBA 12/2018 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 12/2017 - 12/2005
3	ElectrolytesIBA 02/2017 - 11/2010
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2015 - 09/2013
3	Angiotensin IIIBA 09/2014 - 06/2013
3	Aquaporin 2IBA 06/2013 - 09/2006
3	Glycerol (Glycerine)FDA LinkGeneric 08/2006 - 04/2005
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 04/2022 - 08/2021
2	SymportersIBA 01/2022 - 05/2014
2	CollagenIBA 11/2021 - 01/2018
2	LipidsIBA 05/2021 - 05/2018
2	Arginine Vasopressin (Argipressin)IBA 04/2021 - 06/2013
2	Serum AlbuminIBA 01/2021 - 02/2017
2	GlucocorticoidsIBA 01/2021 - 10/2011
2	Vitamin D FDA LinkGeneric 01/2021 - 06/2017
2	Phosphates (Orthophosphate)IBA 01/2021 - 08/2016
2	plasmin receptorIBA 06/2020 - 01/2017
2	Uric Acid (Urate)IBA 01/2020 - 01/2020
2	Insulin (Novolin)FDA Link 01/2020 - 09/2015
2	Tolvaptan FDA Link 01/2020 - 01/2019
2	Scopolamine (Hyoscine)FDA Link 07/2019 - 12/2018
2	Peptides (Polypeptides)IBA 07/2019 - 12/2018
2	Factor XIII (Coagulation Factor XIII)IBA 06/2019 - 06/2017
2	Fibrinogen (Factor I)FDA Link 06/2019 - 06/2017
2	Small Interfering RNA (siRNA)IBA 01/2018 - 03/2008
2	UbiquitinIBA 01/2018 - 01/2016
2	Ligases (Synthetase)IBA 01/2018 - 01/2016
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2018 - 01/2017

Therapy/Procedure

7	Renal Dialysis (Hemodialysis) 01/2021 - 02/2011
5	Therapeutics 06/2020 - 07/2013
2	Protein-Restricted Diet (Diet, Protein Restricted) 01/2019 - 03/2012
2	Catheters 11/2018 - 01/2018